Clarification Of HEK293 Cells Using Centrifugation: Results From The UniFuge® Pilot And The UFMini®

Immortalized Human Embryonic Kidney (HEK) cells are frequently used in the production of gene therapies due to transfection efficiency as well as cell growth in applications such as vaccine manufacturing and process intensification. Manufacturers of gene therapies continue to implement new solutions to optimize their existing process of collecting virus like particles through clarifying HEK293 cells.

The CARR Biosystems team highlights the introduction of the scalable UniFuge family and how it provides manufacturers the ability to obtain efficient results with the clarification of HEK293 cells in various stages of production from research to manufacturing.